Advertisement
Across adult age categories

Cannabis Use Prevalence Up Across Adult Age Groups

0
After 2007, overall increase in adjusted odds of daily versus nondaily cannabis use for ages 12 to 64
The U.S. Centers for Disease Control and Prevention and the American Pharmacists Association have created a guide that describes community-clinical linkages

CDC, APhA Create Guide for Community-Clinical Linkages

0
Guide details two types of collaborative care models that involve pharmacists, docs working together
For Japanese patients with type 2 diabetes

Aspirin Use Doesn’t Cut Cancer Incidence in Older T2DM Patients

0
In subgroup analyses, reduced incidence of cancer seen in participants aged younger than 65 years
Vertical level mergers

Vertical Mergers Could Be Challenging for Primary Care

0
Vertical mergers include providers, insurers, retailers, PBMs; may create new model of primary care
There are opportunities for recalibrating the role of opioids in pain care

Coverage Policies Compared for Back Pain Medications

0
Utilization management common for opioids; often relies on 30-day limits rather than prior authorization
Pediatric exposure to buprenorphine can result in serious adverse outcomes

Poison Control Center Data Detail Peds Exposure to Buprenorphine

0
Children aged <6 have greater odds of hospital admission than teens with single-substance exposure
At the annual meeting of the American Medical Association

AMA: Docs Declare Drug Shortages Public Health Emergency

0
AMA calls for greater manufacturer transparency in order to prepare for disasters, mitigate shortages
For older patients with hepatitis C virus

Direct-Acting Antivirals Effective for Hepatitis C in Seniors

0
Increased likelihood of adverse events, anemia secondary to ribavirin for those age 75 or older
For persons living with HIV in Uganda

Efavirenz Doesn’t Up Depression, Suicidal Ideation in HIV-Infected

0
No increased risk of depression or suicidal ideation among persons living with HIV in Uganda
Concurrent benzodiazepine use is associated with increased risk of opioid-related overdose

Risk of OD Highest for First Days of Opioid + Benzodiazepine Use

0
Five-fold increased risk of opioid-related overdose during first 90 days of concurrent use